Shuttle Pharmaceuticals Holdings (SHPH) Dividends payables (2021)
Shuttle Pharmaceuticals Holdings' (SHPH) quarterly Dividends payables came in at $331059.0 in Q4 2021.
Shuttle Pharmaceuticals Holdings (SHPH) Dividends payables (2021) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Dividends payables history runs 1 years deep, the most recent figure standing at $331059.0 for Q4 2021.
- On a quarterly basis, Dividends payables changed N/A year-over-year to $331059.0 in Q4 2021; TTM through Dec 2021 was $331059.0, a N/A change from a year earlier, with the FY2021 full-year figure at $331059.0, changed N/A from the prior year.
- Dividends payables steadied at $331059.0 in Q4 2021 per SHPH's latest filing.
- Across five years, Dividends payables topped out at $331059.0 in Q4 2021 and bottomed at $331059.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 224.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Shuttle Pharmaceuticals Holdings | 120,186.04 | 120,186.04 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 331,059.00 |